Wei Xiao

机构：Jiangnan University, Wuxi Fourth People's Hospital · ORCID：0000-0001-9244-5477

发表论文 54 篇 · 总被引 2777 次 · h-index 29

代表论文

• Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer (2019 · The Journal of Experimental Medicine · 被引 261)
• TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway (2021 · Journal of Experimental & Clinical Cancer Research · 被引 101)
• Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma (2018 · BMC Cancer · 被引 99)
• Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer (2019 · Journal of Experimental & Clinical Cancer Research · 被引 88)
• 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression (2018 · Journal of Experimental & Clinical Cancer Research · 被引 63)
• PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer (2021 · npj Precision Oncology · 被引 59)